Search results
AACR: BioNTech's Genentech-partnered cancer vax still providing immune response 3 years later
FierceBiotech· 2 weeks agoMeanwhile, the German mRNA company is enrolling a phase 2 test of the therapy, autogene cevumeran,...
China's drugmakers can't sell mRNA shots but haven't quit yet
Reuters via Yahoo News· 5 hours agoChina's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 weeks agoThree-year follow-up data of an investigator-initiated Phase 1 trial of the individualized mRNA cancer vaccine candidate autogene cevumeran (BNT122, RO7198457) continue to show polyspecific ...
Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?
Zacks via Yahoo Finance· 1 week agoTo extend its existing cash runway and curb cash burn, Novavax (NVAX) initiates multiple...
Morgan Stanley lifts Adagene stock target on positive data
Investing.com· 2 weeks agoThe adjustment follows positive developments in the company's cancer treatment research,...
Pfizer wins pause on Moderna's COVID-19 patent lawsuit
Reuters· 7 days ago, opens new tab copied its COVID-19 vaccine technology will be put on hold while the U.S. Patent...
AACR: Cancer vaccines get a reintroduction as readouts support 'path forward' for the tech
FierceBiotech· 1 week agoA session at the American Association for Cancer Research (AACR) annual meeting posed a key...
Experimental Pancreatic Cancer Vaccine May Elicit Lasting Immune Response
Technology Networks· 1 week agoNew data presented today by Memorial Sloan Kettering Cancer Center (MSK) researchers show an...
Ryvu Therapeutics Presents Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024...
Investing.com· 1 week agoRyvu Therapeutics Presents Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024...
African-led clinical research essential to tackling the continent's health care challenges, says...
Medical Xpress· 3 days agoAs witnessed during the pandemic, there is an increasing critical mass of expertise and ability for...